UniProtKB/Swiss-Prot P12830: Variant p.Ala592Thr

Cadherin-1
Gene: CDH1
Feedback?

Variant information Variant position:

592 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Threonine (T) at position 592 (A592T, p.Ala592Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In a thyroid cancer sample; may play a role in colorectal carcinogenesis. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs35187787 [ dbSNP | Ensembl ]

Sequence information Variant position:

592 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

882 The length of the canonical sequence.
Location on the sequence:

SPVATGTGTLLLILSDVNDN A PIPEPRTIFFCERNPKPQVI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVI

                              SPVATGTGTLLLVLSDVNDNGPIPEPRNMDFCQKNPQPHVI

Mouse                         SPIATGTGTLLLVLLDVNDNAPIPEPRNMQFCQRNPQPHII

Rat                           SPIATGTGTLLLVLSDVNDNAPIPEPRNMQFCQRNPKPHVI

Bovine                        SPPATGTGTLLLFLDDVNDNGPVPEPRTMDFCQRNPEPHII

Chicken                       IPDTTGTGTLLLLLQDVNDNGPTPEPRSFEICSRQPEKQIL

Xenopus laevis                SPSATGTGTLVLNLLDVNDNGPFLEPQQESFCQKDPGFRVF

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	155 – 882	Cadherin-1
Topological domain	155 – 709	Extracellular
Domain	487 – 593	Cadherin 4
Glycosylation	576 – 576	O-linked (Man...) threonine
Glycosylation	578 – 578	O-linked (Man...) threonine
Glycosylation	580 – 580	O-linked (Man...) threonine

Literature citations
E-cadherin gene alterations are rare events in thyroid tumors.
Soares P.; Berx G.; van Roy F.; Sobrinho-Simoes M.;
Int. J. Cancer 70:32-38(1997)
Cited for: VARIANT THYROID CANCER THR-592; A germline E-cadherin mutation in a family with gastric and colon cancer.
Salahshor S.; Hou H.; Diep C.B.; Loukola A.; Zhang H.; Liu T.; Chen J.; Iselius L.; Rubio C.; Lothe R.A.; Aaltonen L.; Sun X.F.; Lindmark G.; Lindblom A.;
Int. J. Mol. Med. 8:439-443(2001)
Cited for: VARIANT THR-592;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.